Company Filing History:
2 out of 1,950 
1 out of 3,578 
1 out of 69 
Years Active: 2025
Title: Chi-I Chiang: Innovator in Multispecific Antibodies
Introduction
Chi-I Chiang is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies targeting HIV-1. His innovative work aims to enhance the effectiveness of treatments against this challenging virus.
Latest Patents
Chi-I Chiang holds a patent for "Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope." This invention provides a multispecific anti-HIV antibody that binds to multiple epitopes on the HIV envelope protein. The antibody comprises an amino acid sequence that binds to a V1/V2 apex glycan epitope, a V3-base glycan region epitope, a CD4 binding site (CD4bs) epitope, a gp120/gp41 interface epitope, and a membrane proximal external region (MPER) epitope. This innovative approach has the potential to improve therapeutic strategies against HIV.
Career Highlights
Throughout his career, Chi-I Chiang has worked with esteemed organizations, including the University System of Maryland and the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in these institutions has contributed to advancements in medical research and public health.
Collaborations
Chi-I Chiang has collaborated with notable colleagues, including Yuxing Li and James Steinhardt. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of biotechnology.
Conclusion
Chi-I Chiang's contributions to the development of multispecific antibodies represent a significant advancement in the fight against HIV. His innovative work and collaborations continue to inspire progress in medical research and biotechnology.